Anne M. Koivisto

8.7k total citations
129 papers, 2.5k citations indexed

About

Anne M. Koivisto is a scholar working on Neurology, Psychiatry and Mental health and Physiology. According to data from OpenAlex, Anne M. Koivisto has authored 129 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Neurology, 45 papers in Psychiatry and Mental health and 41 papers in Physiology. Recurrent topics in Anne M. Koivisto's work include Dementia and Cognitive Impairment Research (42 papers), Cerebrospinal fluid and hydrocephalus (37 papers) and Alzheimer's disease research and treatments (35 papers). Anne M. Koivisto is often cited by papers focused on Dementia and Cognitive Impairment Research (42 papers), Cerebrospinal fluid and hydrocephalus (37 papers) and Alzheimer's disease research and treatments (35 papers). Anne M. Koivisto collaborates with scholars based in Finland, United States and Sweden. Anne M. Koivisto's co-authors include Hilkka Soininen, Ville Leinonen, Seppo Helisalmi, Irina Alafuzoff, Sanna‐Kaisa Herukka, Ilona Hallikainen, Tarja Välimäki, Juha E. Jääskeläinen, Mikko Hiltunen and Sakari Savolainen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Anne M. Koivisto

124 papers receiving 2.5k citations

Peers

Anne M. Koivisto
Gregory T. Carter United States
Jesse Mez United States
Scott A. Reines United States
Ming Tang United States
Gregory T. Carter United States
Anne M. Koivisto
Citations per year, relative to Anne M. Koivisto Anne M. Koivisto (= 1×) peers Gregory T. Carter

Countries citing papers authored by Anne M. Koivisto

Since Specialization
Citations

This map shows the geographic impact of Anne M. Koivisto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne M. Koivisto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne M. Koivisto more than expected).

Fields of papers citing papers by Anne M. Koivisto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne M. Koivisto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne M. Koivisto. The network helps show where Anne M. Koivisto may publish in the future.

Co-authorship network of co-authors of Anne M. Koivisto

This figure shows the co-authorship network connecting the top 25 collaborators of Anne M. Koivisto. A scholar is included among the top collaborators of Anne M. Koivisto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne M. Koivisto. Anne M. Koivisto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shah, Hasnain Ali, et al.. (2025). Eye tracking based detection of mild cognitive impairment: A review. Information Fusion. 122. 103202–103202. 1 indexed citations
2.
Ruponen, Marika, Jarkko Rautio, Riikka Lampinen, et al.. (2024). A technological comparison of freeze-dried poly-ɛ-caprolactone (PCL) and poly (lactic-co-glycolic acid) (PLGA) nanoparticles loaded with clozapine for nose-to-brain delivery. Journal of Drug Delivery Science and Technology. 93. 105419–105419. 9 indexed citations
3.
Kuivanen, Suvi, Alexey М. Afonin, Anne M. Koivisto, et al.. (2024). Exposure to urban particulate matter alters responses of olfactory mucosal cells to SARS-CoV-2 infection. Environmental Research. 249. 118451–118451.
4.
Ruponen, Marika, Jarkko Rautio, Carla Ghelardini, et al.. (2023). Development of Lyophilised Eudragit® Retard Nanoparticles for the Sustained Release of Clozapine via Intranasal Administration. Pharmaceutics. 15(5). 1554–1554. 8 indexed citations
5.
Paajanen, Teemu, Christer Hublin, Johanna Krüger, et al.. (2023). The Cognitive Function at Work Questionnaire in memory clinic setting: a validation study. Journal of Clinical and Experimental Neuropsychology. 45(4). 365–376. 1 indexed citations
6.
Kokkola, Tarja, Anne M. Koivisto, Merja Kokki, et al.. (2023). Cerebrospinal Fluid Diagnostics of Alzheimer’s Disease in Patients with Idiopathic Normal Pressure Hydrocephalus. Journal of Alzheimer s Disease. 94(2). 727–736. 5 indexed citations
7.
Kuivanen, Suvi, Riikka Lampinen, Tomáš Hron, et al.. (2023). Human-derived air–liquid interface cultures decipher Alzheimer’s disease–SARS-CoV-2 crosstalk in the olfactory mucosa. Journal of Neuroinflammation. 20(1). 299–299. 5 indexed citations
8.
Junkkari, Antti, Harri Sintonen, Nils Danner, et al.. (2021). 5-Year health-related quality of life outcome in patients with idiopathic normal pressure hydrocephalus. Journal of Neurology. 268(9). 3283–3293. 10 indexed citations
9.
Saari, Toni, Ilona Hallikainen, Taina Hintsa, & Anne M. Koivisto. (2020). Network structures and temporal stability of self- and informant-rated affective symptoms in Alzheimer's disease. Journal of Affective Disorders. 276. 1084–1092. 8 indexed citations
10.
Junkkari, Antti, Ville E. Korhonen, Mitja Kurki, et al.. (2019). Prevalence of schizophrenia in idiopathic normal pressure hydrocephalus. University of Oulu Repository (University of Oulu). 15 indexed citations
11.
Rinne, Juha O., Jaana Rummukainen, Sanna-Kaisa Herukka, et al.. (2019). [11C]PIB PET Is Associated with the Brain Biopsy Amyloid-β Load in Subjects Examined for Normal Pressure Hydrocephalus. Journal of Alzheimer s Disease. 67(4). 1343–1351. 10 indexed citations
12.
Junkkari, Antti, Nils Danner, Tuomas Rauramaa, et al.. (2019). The Kuopio idiopathic normal pressure hydrocephalus protocol: initial outcome of 175 patients. Fluids and Barriers of the CNS. 16(1). 21–21. 31 indexed citations
13.
Katisko, Kasper, Eino Solje, Anne M. Koivisto, et al.. (2018). Prevalence of immunological diseases in a Finnish frontotemporal lobar degeneration cohort with the C9orf72 repeat expansion carriers and non-carriers. Journal of Neuroimmunology. 321. 29–35. 18 indexed citations
14.
Törmälehto, Soili, Janne Martikainen, J. Simon Bell, Ilona Hallikainen, & Anne M. Koivisto. (2017). Use of psychotropic medications in relation to neuropsychiatric symptoms, cognition and functional performance in Alzheimer's disease over a three-year period: Kuopio ALSOVA study. International Psychogeriatrics. 29(10). 1723–1733. 15 indexed citations
15.
Junkkari, Antti, Risto Roine, Tuomas Rauramaa, et al.. (2017). Why Does the Health-Related Quality of Life in Idiopathic Normal-Pressure Hydrocephalus Fail to Improve Despite the Favorable Clinical Outcome?. World Neurosurgery. 108. 356–366. 8 indexed citations
16.
Kokkonen, Nina, Sanna‐Kaisa Herukka, Laura Huilaja, et al.. (2016). Increased Levels of the Bullous Pemphigoid BP180 Autoantibody Are Associated with More Severe Dementia in Alzheimer’s Disease. Journal of Investigative Dermatology. 137(1). 71–76. 59 indexed citations
17.
Hallikainen, Ilona, Janne Martikainen, Pei‐Jung Lin, et al.. (2014). The Progression of Alzheimer's Disease Can Be Assessed with a Short Version of the CERAD Neuropsychological Battery: The Kuopio ALSOVA Study. Dementia and Geriatric Cognitive Disorders Extra. 4(3). 494–508. 3 indexed citations
18.
Martikainen, Janne, Hannu Kautiainen, Saku Väätäinen, et al.. (2013). Effectiveness of the Early Psychosocial Intervention on Institutionalization of Patients with Mild Alzheimer’s Disease and Caregivers’ Quality of Life – An Alsova Study. Value in Health. 16(7). A618–A619. 1 indexed citations
19.
Hiltunen, Mikko, Seppo Helisalmi, Arto Mannermaa, et al.. (2000). Identification of a novel 4.6-kb genomic deletion in presenilin-1 gene which results in exclusion of exon 9 in a Finnish early onset Alzheimer's disease family: an Alu core sequence-stimulated recombination?. European Journal of Human Genetics. 8(4). 259–266. 38 indexed citations
20.
Hiltunen, Mikko, Arto Mannermaa, Seppo Helisalmi, et al.. (1998). Butyrylcholinesterase K variant and apolipoprotein E4 genes do not act in synergy in Finnish late-onset Alzheimer's disease patients. Neuroscience Letters. 250(1). 69–71. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026